UBS Group’s Silver Standard Resources SSRI Stock Holding History

UBS Group’s Portfolio SSRI Stock Details SSRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-15,900	Closed	-$82K	–	8891
2015 Q4	$82K	Buy	15,900 +15,000	+1,667%	+$90.2K	﹤0.01%	5380
2015 Q3	$6K	Sell	900 -1,400	-61%	-$8.52K	﹤0.01%	7677
2015 Q2	$14K	Sell	2,300 -10,300	-82%	-$60.8K	﹤0.01%	7233
2015 Q1	$57K	Buy	12,600 +4,600	+58%	+$25.6K	﹤0.01%	5930
2014 Q4	$40K	Buy	+8,000	New	+$42K	﹤0.01%	6788

Other funds holding SSRI

SCP

Syntal Capital Partners Midland, Texas $10M AUM 35.51% 1-Year Est. Return

UBS Group's SSRI Position: Q3 2017 in Review

UBS Group sold out of Silver Standard Resources (SSRI) in Q3 2017, closing a stake of 478,104 shares — an estimated $4.64M sold.

UBS Group first reported a position in SSRI in Q4 2014 and held it in 11 quarters. The position peaked at $4.64M in Q2 2017. 1 fund tracked by Wall St. Rank holds SSRI as of Q3 2017.

UBS Group reported no remaining Silver Standard Resources position as of Q3 2017 after selling out during the quarter.
UBS Group sold 478,104 Silver Standard Resources shares in Q3 2017, an estimated $4.64M.
UBS Group first reported a position in Silver Standard Resources in Q4 2014 and held it in 11 quarters.
UBS Group's Silver Standard Resources position peaked at $4.64M in Q2 2017.
1 fund tracked by Wall St. Rank held Silver Standard Resources as of Q3 2017.

Based on UBS Group's 13F filing for Q3 2017, filed 14 Nov 2017.